Antibody–exatecan conjugates with a novel self-immolative moiety overcome resistance in colon and lung cancer

W Weng, T Meng, Q Zhao, Y Shen, G Fu, J Shi… - Cancer Discovery, 2023 - AACR
Antibody–drug conjugates (ADC) using DNA topoisomerase I inhibitor DXd/SN-38 have
transformed cancer treatment, yet more effective ADCs are needed for overcoming …
被引用次数：18 相关文章

Antibody–Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer

W Weng, T Meng, Q Zhao, Y Shen, G Fu, J Shi… - Cancer Discovery, 2023 - AACR
Antibody–drug conjugates (ADC) using DNA topoisomerase I inhibitor DXd/SN-38 have
transformed cancer treatment, yet more effective ADCs are needed for overcoming …

Antibody-Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer

W Weng, T Meng, Q Zhao, Y Shen, G Fu… - Cancer …, 2023 - pubmed.ncbi.nlm.nih.gov
Antibody-drug conjugates (ADC) using DNA topoisomerase I inhibitor DXd/SN-38 have
transformed cancer treatment, yet more effective ADCs are needed for overcoming …

Antibody-exatecan conjugates with a novel self-immolative moiety overcome resistance in colon and lung cancer.

W Weng, T Meng, Q Zhao, Y Shen, G Fu, J Shi… - Cancer …, 2023 - europepmc.org
Antibody-drug conjugates (ADCs) using DNA Topoisomerase I inhibitor DXd/SN-38 have
transformed cancer treatment, yet more effective ADCs are needed for overcoming …